Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.84
+0.63 (10.14%)
At close: Jun 26, 2026, 4:00 PM EDT
6.71
-0.13 (-1.90%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 76 employees as of December 31, 2025. The number of employees increased by 5 or 7.04% compared to the previous year.
Employees
76
Change (1Y)
5
Growth (1Y)
7.04%
Revenue / Employee
$488,961
Profits / Employee
-$234,553
Market Cap
117.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Alps Group | 93 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Aardvark Therapeutics | 40 |
| Oncolytics Biotech | 29 |
| Cue Biopharma | 29 |
| Cognition Therapeutics | 14 |
VRCA News
- 6 days ago - Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts - GlobeNewsWire
- 23 days ago - Verrica Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Verrica Pharmaceuticals assumed with a Buy at H.C. Wainwright - TheFly
- 5 weeks ago - Verrica Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 6 weeks ago - Verrica Pharmaceuticals reports Q1 adjusted EPS (41c), consensus (59c) - TheFly
- 6 weeks ago - Verrica Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts